These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22166427)

  • 1. Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S177-9. PubMed ID: 22166427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
    Fishman-Jacob T; Youdim MBH
    J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component, SKP1A.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S148-51. PubMed ID: 20082978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A.
    Fishman-Jacob T; Reznichenko L; Youdim MB; Mandel SA
    J Biol Chem; 2009 Nov; 284(47):32835-45. PubMed ID: 19748892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing/overexpressing selected genes as a model of sporadic Parkinson's disease.
    Fishman-Jacob T; Youdim MB; Mandel SA
    Neurodegener Dis; 2010; 7(1-3):108-11. PubMed ID: 20173338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SKP1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease.
    Mandel SA; Fishman-Jacob T; Youdim MB
    Neurodegener Dis; 2012; 10(1-4):220-3. PubMed ID: 22205206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration.
    Frank-Cannon TC; Tran T; Ruhn KA; Martinez TN; Hong J; Marvin M; Hartley M; Treviño I; O'Brien DE; Casey B; Goldberg MS; Tansey MG
    J Neurosci; 2008 Oct; 28(43):10825-34. PubMed ID: 18945890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease.
    Yoo MS; Chun HS; Son JJ; DeGiorgio LA; Kim DJ; Peng C; Son JH
    Brain Res Mol Brain Res; 2003 Jan; 110(1):76-84. PubMed ID: 12573535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: a broken nosology.
    Hardy J; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S2-4. PubMed ID: 16092073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological mechanisms of Parkinson's disease].
    Matsui H; Takahashi R
    Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription--potential to delay Parkinson's disease.
    Lauterbach EC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():236-9. PubMed ID: 23046827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.